Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer
Clinical trial NCT00268892 · COMPLETED
Trial details
- NCT number
- NCT00268892
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2009-09-01
- Enrollment
- 278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.